aponcome-blog

[aponcome-blog]

This World Cancer Day, we assert that, we are in the fight against cancer. We have been helping cancer fighters and oncologist to #CloseTheCareGap with our prognostic test, CanAssist Breast. Here is what Dr Radhyshyam Joshi, Husband of Renu Joshi has to say about how #OncoStem's #CanAssistBreast helped to take an informed decision in his wife's breast cancer treatment. To know more about OncoStem: https://www.oncostem.com/

[aponcome-blog]

#Prognostic tests help early-stage hormone-positive and HER2-negative breast cancer patients to personalize their treatment plan leading to improved quality of life, substantial cost savings by avoiding chemotherapy. Know more about the only prognostic test validated on Indian breast cancer patients.

Click here to know more at https://oncostem.com/

[aponcome-blog]

CanAssist Breast is a prognostic test developed by OncoStem that classifies the early-stage, hormone receptor-positive breast cancer patients as ‘low-risk’ or ‘high-risk’ based on the patient’s risk of breast cancer recurrence over five years. This test analyses critical biomarkers in the tumour to assess the risk of recurrence, and helps oncologists to personalize treatment plans and avoid chemotherapy for many.